The US Court of Appeals for the Third Circuit has ruled that a fax sent by a major healthcare support services company to a Florida pharmacy about an anticoagulant prescription drug could be considered an unsolicited advertisement under the Telephone Consumer Protection Act, reviving a class action that a lower
Third circuit says pharma fax violated TCPA
1 min read
The Third Circuit has ruled a fax about a blood thinner could qualify as an unsolicited advertisement under the TCPA.